Obstetric and Gynecologic Dermatology E-Book, 3rd Edition
|(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)|
Highly Commended, Dermatology, BMA Awards 2009
Completely updated throughout-and still the only reference of its kind-the new edition of this well-respected resource offers you a practical guide for the evaluation, diagnosis, and management of a full range of common and uncommon obstetric and gynecologic skin disorders. Expanded coverage-including chapters on vulval vaginal disease help you meet more clinical challenges, while more than 460 illustrations emphasize pathologic and clinical appearances of dermatologic problems, providing essential visual guidance for the most informed diagnoses. Enhanced basic dermatologic information, such as general introductions to treatment, treatment options, and rashes, makes this an excellent guide for dermatologist and non-dermatologists, as well as obstetricians and gynecologists.
New to This Edition
- Provides new information and illustrations in an expanded vulval section that equip you with a wider range of gynecologic dermatoses and treatment options for your most challenging clinical cases.
- Features the contributions of two new internationally recognized editors-known for their work in genital dermatology-who broaden the global appeal and relevance of the coverage.
- Features the contributions of a team of international experts who provide a global perspective on today's best practices.
- Provides exceptional visual guidance of both obstetric and gynecologic dermatoses, making this a convenient one-stop consultation reference.
- Includes more than 460 illustrations that clarify the key features of diseases and provide a greater "true-life" practice perspective for making accurate diagnoses.
- Covers a full spectrum of conditions, including vulvar dermatoses, dermatoses of pregnancy, effect of pregnancy on other skin disorders, and more, to help you meet a full range of clinical challenges for diverse patient populations.
By Martin M. Black, MD, FRCP, FRCPath, Professor of Dermatological Immunopathology, St. John's Institute of Dermatology, Guy's King's and St Thomas' School of Medicine, St. Thomas Hospital, London, UK